Abstract

BackgroundSupporting Our Valued Adolescents (SOVA), a social media website for adolescents, was designed to increase mental health literacy and address negative health beliefs toward depression and/or anxiety diagnosis and treatment. This stakeholder-informed site underwent iterative user testing to evolve into its current version with daily blog posts, round-the-clock site moderation, and Web-based peer interaction to create an online support community.ObjectiveThe aim of this study was to evaluate the technological feasibility (at least 100 users on the site, logging in 12 to 18 times in the first 6 weeks) and acceptability of the SOVA site determined by the System Usability Scale (SUS).MethodsAdolescents and young adults (aged 14-26 years) with a self-reported history of depressive and/or anxiety symptoms were recruited to access the research website (sova.pitt.edu). Participants were screened out if they reported active suicidality or a prior suicide attempt. Baseline survey measures included demographics, symptomatology using the Patient Health Questionnaire-9 modified for adolescents (PHQ-9A) and Screen for Child Anxiety Related Disorders (SCARED-C), and mental health treatment history. The 6-week follow-up measures taken in addition to the symptomatology, included feasibility (total number of log-ins), usability, and acceptability of SOVA using SUS.ResultsMost of the 96 participants identified as female (75% [72/96]) and white (67% [64/96]). Most participants (73% [70/96]) reported having taken prior professional psychological help. The average PHQ-9A score was 11.8 (SD 5.5), and for SCARED-C, 85% (80/94) of the participants reported a score consistent with being susceptible to a diagnosed anxiety disorder. There were 46% (41/90) of eligible users who ever logged in. Out of the total users who ever logged in, the mean of total log-ins over the entire study was 4.1 (SD 6.9). Median number of users rated the user-friendliness of the site as “good.” The average SUS score was 71.2% (SD 18.7), or a “C-grade,” which correlated to an acceptable range. The participants reported to have liked the “easy-to-understand format” and “positive, helpful atmosphere,” but they also reported a desire for greater social interaction. Iterative recruitment resulted in incremental improvements to the site.ConclusionsThe SOVA site met feasibility goals of recruiting almost 100 users and establishing acceptable usability. Subsequent interventions are planned to increase site engagement and to evaluate efficacy in increasing uptake of primary care–recommended depression and/or anxiety treatment.

Highlights

  • Data for races other than white and black should be interpreted with caution because of inconsistencies between the reporting of race on death certificates and on censuses and surveys]

  • Category not applicable * Figure does not meet standards of reliability or precision --- Data not available 1 Rank based on number of deaths

  • All causes 1 Accidents (V01-X59,Y85-Y86) 2 Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) 3 Malignant neoplasms (C00-C97) 4 Diseases of heart (I00-I09,I11,I13,I20-I51) 5 Assault (*U01-*U02,X85-Y09,Y87.1) 6 In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48) 6 Influenza and pneumonia (J09-J18) 8 Acute bronchitis and bronchiolitis (J20-J21) 8 Chronic lower respiratory diseases (J40-J47) 8 Pneumonitis due to solids and liquids (J69) 8 Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27) 8 Certain conditions originating in the perinatal period (P00-P96)

Read more

Summary

Introduction

All causes 1 Accidents (unintentional injuries) (V01-X59,Y85-Y86) 2 Intentional self-harm (suicide) (*U03,X60-X84,Y87.0) 3 Assault (homicide) (*U01-*U02,X85-Y09,Y87.1) 4 Malignant neoplasms (C00-C97) 5 Diseases of heart (I00-I09,I11,I13,I20-I51) 6 Diabetes mellitus (E10-E14) 7 Chronic liver disease and cirrhosis (K70,K73-K74) 8 Human immunodeficiency virus (HIV) disease (B20-B24) 9 Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) Pregnancy, childbirth and the puerperium (O00-O99) Cerebrovascular diseases (I60-I69) Influenza and pneumonia (J09-J18) Septicemia (A40-A41) Chronic lower respiratory diseases (J40-J47) Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27) 15 Legal intervention (Y35,Y89.0) ...

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call